Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study.
about
Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Efficacy and safety of twice-d ...... the Japan-based EXTEND study.
@en
Efficacy and safety of twice-d ...... the Japan-based EXTEND study.
@nl
type
label
Efficacy and safety of twice-d ...... the Japan-based EXTEND study.
@en
Efficacy and safety of twice-d ...... the Japan-based EXTEND study.
@nl
prefLabel
Efficacy and safety of twice-d ...... the Japan-based EXTEND study.
@en
Efficacy and safety of twice-d ...... the Japan-based EXTEND study.
@nl
P2093
P2860
P1476
Efficacy and safety of twice-d ...... the Japan-based EXTEND study.
@en
P2093
Hironori Masuyama
Hisanori Abe
Mitsuhiro Fujishiro
Mototsugu Kato
Motoyasu Kusano
Ryo Nakata
Seiichiro Hojo
Shinji Kumagai
Yasushi Fukushima
Yoshikazu Kinoshita
P2860
P304
P356
10.1007/S00535-017-1417-Z
P577
2017-11-29T00:00:00Z